From: Recurrent erysipelas - risk factors and clinical presentation
Single episode | Recurrent episodes | p-value | |
---|---|---|---|
n = 360 (100%) | n = 142 (100%) | ||
Age, years (SD) | 58.0 (18.7) | 61.5 (16.1) | 0.05 |
Gender,% male | 211 (58.6) | 75 (52.8) | 0.24 |
Time since onset | <0.01 | ||
<12 hrs | 47 (13.1) | 39 (27.5) | |
13-48 hrs | 144 (40.0) | 49 (34.5) | |
>48 hrs | 85 (23.6) | 29 (20.4) | |
Missing | 84 (23.3) | 25 (17.6) | |
Localization 1) | <0.01 | ||
Lower limbs | 231 (64.2) | 111 (78.2) | |
Upper limbs | 60 (16.7) | 15 (10.6) | |
Thorax/trunk | 24 (6.7) | 11 (7.6) | |
Head/face | 45 (12.5) | 6 (3.5) | |
CRP, median (range) | 88 (0–513) | 66 (2–438) | 0.28 |
Missing | 57 (15.8) | 29 (20.4) | 0.22 |
WBC, median (range) | 11 (2.7-68) | 13 (2.6-28) | 0.82 |
Missing | 73 (20.3) | 31 (21.8) | 0.70 |
Inpatient treatment | 211 (58.6) | 67 (47.2) | 0.03 |
Initial iv antibiotics | 239 (67.0) | 84 (59.6) | 0.18 |
Length of hospital stay, median (range) | 5 (1–34) | 5 (1–22) | 0.61 |